Tag
CyPath Lung
- bioAffinity Technologies reports more than 1,620 CyPath Lung tests
- bioAffinity Technologies jumps 63% on Hong Kong lung cancer screening patent
- bioAffinity jumps 45% from lung cancer phlegm test expansion
- PrognomiQ shares promising early results from novel lung cancer blood test
- bioAffinity Technologies soars Monday as non‑invasive lung cancer tech gains traction
- bioAffinity launches 2,000‑patient study for noninvasive lung cancer test
- bioAffinity Technologies shines After CyPath Lung Clinical case studies
- bioAffinity Technologies obtains Canadian patent for lung cancer spit test
- bioAffinity Technologies secures Australian patent for 'CyPath Lung' spit test